Fox Chase Updates in Bladder and Kidney Cancer 2019

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this program is designed for clinicians who want to stay abreast of the latest advances in bladder and kidney cancer and apply them to their clinical practice. Physicians will present the latest research and its ...
read more ↘

 

Bladder
13:44

Fox Chase Updates in Bladder and Kidney Cancer 2019

2019 Updates in the Management of Non-Muscle Invasive Bladder Cancer: Enhanced Cystoscopy, Urine Markers After Diagnosis, Chemotherapy Options and Checkpoint Inhibition

FEATURING J. Ryan Mark
  • 690 views
  • November 22, 2019
  • 2
13:40

Fox Chase Updates in Bladder and Kidney Cancer 2019

Muscle-Invasive Bladder Cancer: Who Are the Ideal Candidates for Bladder Preservation and How Do Outcomes Compare to Radical Cystectomy / Therapy for Patients w/ Medically Inoperable Disease and How to Improve Tolerability of Treatment?

FEATURING Mark A. Hallman
  • 441 views
  • November 22, 2019
  • 4
19:10

Fox Chase Updates in Bladder and Kidney Cancer 2019

2019 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma: Cisplatin as SoC, Pembro Mono as Alternative for Cis-Ineligible, Chemo +/- Atezolizumab vs. Atezolizumab Alone, Enfortumab Vedotin + Pembro, and Subsequent Therapies

FEATURING Elizabeth R. Plimack
  • 437 views
  • November 22, 2019
  • 4
15:42

Fox Chase Updates in Bladder and Kidney Cancer 2019

Bladder Cancer Panel Discussion: Management of Non-Muscle Invasive Bladder Cancer, Trimodality Therapy, 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma

FEATURING Robert G. Uzzo
  • 130 views
  • November 22, 2019